1-year mortality
10-eo-cfu
28-day mortality
28-day survivors
30-day death
30-day readmissions
72-hour cumulative urine volume
8-fluo-camp binding
abc2
abdominal problems
abnormal body composition
abnormal cardiac t2
abnormal hr variability
abnormal liver texture
abnormal scn5a mrna splicing
absorption function
accountable
accounting
acetylcholinesterase inhibitor pyridostigmine
acquired heart failure
acs procedures
actin cytoskeleton pathways
activated neurohormonal systems
activated t cells
activation
activators
active individuals
active treatment
activity
actrn
acute anthracycline-induced cardiotoxicity
acute autonomic nervous system modulation
acute care hospital
acute care hospitals
acute decompensated hf
acute heart failure trials
acute hf diagnosis
acute hf trials
acute hospital
acute pulmonary embolism
acute rv decompensation
acute treatment
acute β-adrenoceptor blockade
acute β-ar stimulation
ad-c
ad-c rats
ad-flk
ad-flk rats
adaptive
adenoviral vector
adenyl cyclase
adherence
adjunctive treatment
adjusted ankle-brachial index
adjusted hazard ratio
adjusted hazard ratios
administration
administrative databases
administrative health data
admission median
admission to discharge
adults
advanced chronic obstructive pulmonary disease
advanced copd
advanced disease
advanced heart failure
advanced heart failure therapy
adverse cardiovascular
adverse cv events
adverse event profile
adverse event rates
adverse health
aerobic
aerobic exercise
aerobic exercise training
aerobic training
af pacientes
af type
af-free probability
afterload burden
age
age-by-lvef
age-dependent effect
aggressive protocols
aging
aim
air pollution
akt
albumin level
albumin levels
alcohol
aldactone evaluation study
aldosterone antagonist eplerenone
aldosterone antagonist therapy
all-cause
allopurinol rats
alphalisa immunoassays
altered ventricular structure
ambient air pollution
ambulatory heart failure trial
ambulatory hf
ambulatory icd patients
ambulatory patients
american
ami mortality rates
amyloidotic pattern
an
anabolic imbalance
anesthetized dogs
ang ii infusion mouse model
angeli
angiotensin converting enzyme inhibitors intolerance
angiotensin ii infusion
angiotensin receptor antagonist valsartan
angiotensin receptor blockers therapy
animals
annular size reduction
ans
ans mice
anterior leaflet opening
anthracycline metabolism
anthracycline-containing chemotherapy
anthracycline-related congestive heart failure
anthracycline-treated breast cancer
anti-inflammatory effects
anti-neoplastic
antiarrhythmic medication
antirheumatic drug
antitumor activity
anxiety
aortic blood flow
aortic pressure curve
aortic valve oversewing
aortic valve procedures
aortic valve repairs
aortic valve replacement
aortic valve surgery
apical rotation
arg16
arg83gly
aric hf
aric hf model
arrhythmia events
arrhythmia substrate
arrhythmia-related costs
arterial compliance
artificial pulse
as
assays
atheromatous coronary disease
athletes
atp demand
atp production rates
atrial explant-derived c-kit
atrial structure
atropine infusion
augment cardiac output
autonomic modulation
autonomic nervous system activity
autopsy samples
avd variation
axis
b
b act
b treatment
b-treated
b-type natriuretic peptide levels
band of activated caspase
baroreflex activity therapy
barriers to exercise
basal
basal contractility
basal rotations
baseline ea
baseline ecgs
baseline echocardiography
baseline ef
baseline egfr group
baseline electrocardiogram
baseline glomerular filtration rate
baseline hgb
baseline hrqol
baseline serum creatinine level
baseline sst2 status
battery score
battery scores
bb therapy
bcl-2 mrna expression
bcl-2 proteins
bcl-2/bax
beagle dogs
beat-to-beat qt interval
beat-to-beat qt intervals
behavioural-change
bem
bem-crt
bet inhibition
beta-blocker dose
beta-blocker hypo-response
beta-blocker therapy
beta-dependent yield
bhlh transcription factor
bioinformatic
biological
biomarker studies
biomarker-guided clinical trial design
biomarker-guided clinical trials
biomedical reasons
biomedical treatment
black ethnicity
black patients
black race
blacks
blinded core laboratory
blockade
blood loss
blood pressure control
blood testing
blood work drawn
blood-flow paths
blunted cardiac β-ar responsiveness
blunts
bnp level
bnp levels
body
body composition
body fat distribution
body mass
body weight
bone morphogenetic protein
borderline
bottleneck shape
bottleneck stent model
bradycardia induced
branch block electrical activation sequence
breakdown
breast cancer patients
breath-holding
breathing control
bridging therapy
brief hypothermic circulatory arrest
bromodomain inhibition halts heart failure
bt
budget
bundle
c-kit
c-terminally processed forms
c-terminally truncated fragments
c57b
ca(2+)-pump
ca(2+)-uptake
calf muscle
california office of statewide health planning and development patient discharge data
caloric restriction
camp hydrolytic activity
camp levels
camp production
camp-dependent protein kinase
campbell
cancer
cancers
canine model
carbohydrates
cardiac autonomic balance
cardiac benign tumors
cardiac biology
cardiac c-k
cardiac centre
cardiac development
cardiac diameters
cardiac explant c-kit
cardiac explant-derived cells
cardiac gene control
cardiac genes
cardiac hypertrophic response
cardiac hypertrophy secondary to pressure-overload
cardiac insulin-resistance
cardiac l-type channel activity
cardiac magnetic resonance postcontrast
cardiac magnetic resonance t1
cardiac mena deletion
cardiac mrna levels
cardiac myocyte-specific mena overexpression
cardiac na+ current
cardiac nurse
cardiac nurses
cardiac pathogenesis
cardiac pathology
cardiac pathophysiology
cardiac patients
cardiac performance
cardiac plasma membrane levels
cardiac procedures
cardiac risk
cardiac sodium current
cardiac specialty hospital
cardiac surgery
cardiac sympathetic tone
cardiac sympathovagal balance
cardiac symptoms
cardiac tissue
cardiac tissues
cardiac transplant recipients
cardiac transplant survival
cardiac vagal
cardiac vagal tone
cardiologist
cardiology practices
cardiology-cardiovascular surgery
cardiomyocyte-like cells
cardiomyopathic restriction to flow
cardiomyopathy questionnaire
cardioprotective effect
cardiopulmonary exercise variables
cardiovascular complications
cardiovascular conditions
cardiovascular event rate
cardiovascular event-free rate
cardiovascular health
cardiovascular hospitalization
cardiovascular outcomes
cardiovascular risk factors
cardiovascular surgeons
cardiovascular system
cardioverter-defibrillator therapy
cardorespiratory
care
care management
care packages
carotid bodies
case report
case-control study
caspase 3 expression
caspase-3 activity
caspase-3 gene expression
catabolism
catalytic
catecholamine infusions
catheter system
catheter-based percutaneous revascularization
catheter-based revascularization
caucasian
cause mortality
cav1.3 channels
cd
cd hf
cd133
cd34
cdp choline
cell differentiation
cell expansion protocols
cell yield
centers for medicare
central glycosylated
central pattern generator
centrimag right ventricular assist device
centrimag rvad
cerebral blood flow
cf devices
cf lvad
cgm
cgm synthesis
chagas
change
change of diet in renal disease
channels
charm programme
chart review
chelation choices
chelation regimens
chemical instability
chemotherapy-induced heart failure
chest radiation
chf atrial explants
chf inhibition
chf patients
chf patients intubated
chf predictive model
chf treatments
chf visit rates
chf-derived c-k
chf-developed infarcted animals
chf-dnx
chf-inv
chf-inv rabbits
childhood malignant disease
children
chinese herbal medicine
chm
chromatin-dependent signal transduction
chromatin-mediated signal transduction
chronic advanced heart failure patients
chronic disease
chronic heart failure induced
chronic hf-ref
chronic inflammatory state
chronic insulin exposure
chronic kidney disease epidemiology
chronic stable guideline-directed medical therapy
chronic β-ar stimulation
circulating cd34
circulating fragments
circulating mediator of insulin resistance
circulating nt-probnp
circulating plasma ne
circulatory derangement
circumferential shortening
claims
class i recommendations
class ii heart failure
class iii
clcnka snp
clin
clinical care
clinical care delivery
clinical change
clinical composite response
clinical deterioration
clinical diastolic dysfunction
clinical doppler echocardiography
clinical excellence
clinical modification codes
clinical outcomes
clinical practice
clinical prediction rule
clinical status
clinical studies
clinical trial
clinical trial registries
clinical trials
clinical variables
clnka
clnka gg
clnka polymorphism
closure
cm
cms metric
co correlated
co-activating transcription factor networks
co-morbidity burden
cochrane effective practice
cod
cogeneration
cognitive function
cognitive impairment
collagen density
colon
comanagement
commissioning
community-based programmes
competing risk
competitive
composite quality
computed tomographic angiography
computing readmissions
concurrent hf
conditional gene-targeted hand2 mice
conduction abnormalities
confounders
congenital abnormalities
congenital accessory pathways
congenital heart lesions
congenital lesions
congestion-like
congestive heart failure exacerbation
congestive heart failure phenotypes
congestive heart failure trial
congestive heart failure visits
congestive symptoms
conscious dogs
contact
contemporary heart failure
content-driven telehealth technology
contracting ventricles
contrast agent
control
control adenovirus
control group
controlled trial investigating outcomes
controlled trial investigating outcomes of exercise training
cooper center
cornerstone of heart failure
corporeal membrane oxygenation
cost
cost-effective
cost-effectiveness
cost-effectiveness limits
cost-effectiveness model
costs
counterbalance
coupling
cox proportional hazard
cox proportional hazards
cp
cp-recommended pharmacological treatment
cpet guiding exercise rehabilitation
cps
creatine kinase activity
crf distribution
cronbach
crt group
crt implantation
crt off
crt on
crt on assignment
crt response
crt-d recipients
crude
crude rates of severe hyperkalemia
crude rr
cultured cardiomyocytes
cumulative administration
cumulative anthracycline exposure
cumulative urine volume
current amplitude
currents
curve
cutoff
cutoff level
cutoff value
cv deaths
cv events
cxl-1020 converts
cystatin c level
cytotoxic effect
danish heart failure database
dapc protein levels
dash diet scores
data
deactivation
debilitating stroke
decisions
decline
decongestion
decongestion end point
decoy
defense mechanism
defibrillator-crt
defibrillator-only therapy
deficits
degradation
delayed rhythm control
dementia
depressed left ventricular
depression
depressive symptoms
derivation cohort
desensitization
detergent
developmental chromatin remodeling
device
device implantation
device therapie
devices
dgs
diabetes status
diabetic zsf1 rats
diagnostic devices
diagnostic evaluations
diagnostic procedure
diagnostic procedures
diagnostic test
dialysis patients
dialysis-dependent patients
diameter stenosis
diastolic indices
die
died
diet
diet adherence
diet group
diet score
diet scores
dietary interventions
dietary recommendations
dietary sodium restriction
differential g-protein coupling
diffuse myocardial changes
direct observation
direct renin inhibitors
disappearance
discharged alive
discharged patients
disclosing prognosis
discrimination
disease management
disease management programs
disease progression
disease recapitulates
diseased cardiomyocytes
diseased human
distance
distressing implantable cardioverter-defibrillator shocks
disturbed intestinal barrier
dithiothreitol
diuretic efficacy
diuretic refractory severe-end-stage hf
diuretic resistant volume overload
diuretic response
diuretic therapy
dna accessibility
dogs
dose uptitration
dose-related gradient
double mutant
downstream
downward regression line shift
doxorubicin cardiotoxicity
doxorubicin-induced heart failure
dp-4 inhibitors
driveline infection
driveline injury
drs-stratified analyses
drs-stratified hazard ratios
drug abrogated
drug dose
drug-free
dyn
dynamic
dynamic resistance training
e
e-lateral
e/e
e/e'septal
e/elateral
e/emean
e/eseptal
early diastolic mitral annular velocity
early diastolic mitral annulus velocity
early risk
early transmitral blood flow velocity
early transmitral flow
early-onset
early-onset hf
ec coupling gain
eccentric
ecg parameters
echo-doppler studies
echocardiographic assessment
echocardiographic evaluations
echocardiographic evidence
echocardiographic examination
echocardiographic measurements
echocardiographic measures
echocardiographic outcomes
echocardiographic predictors
echocardiographic score
echocardiographic systolic parameters
ecmo group
ecmo+vad group
ecmo+vad groups
economic
economic analysis
economic climate
economic evaluations
economic impact
economic models
economic savings
ecr
ed physicians
ed visits
ed volume
effective rate
efficiency
egf
egfr group
elastic n2bus segment
elderly
elderly patients hospitalized
electric remodeling
electrical activation
electrical stimulation
electrocardiographic device
electrocardiographic measures
electromechanical behavior
electronic databases
elevated lv filling pressures
elevated resistin
eligibility
embryonic gene programs
embryonic kidney
emd prolongation
emergency
emergency cardiac catheterization
emotional status
emotional stress
empirically
end point of death
end stage
end stage kidney failure
end systolic volume index
end-diastolic area
end-diastolic dimension
end-of-life
end-stage congestive heart failure
end-tidal co2
endothelial repair
endothelial-protective effects
energy deficit
energy expenditure
enos-ser
enos-thr
enrollment
enrollment period
epigenetic changes
epigenetic readers
er kinase
erasers
erc induced recovery
erk1/2 molecular scaffolds
erk1/2 signalling
erythropoiesis-stimulating agent therapy
et
et exerts
ethically
european hf
evaluation
event rate
events
evidence
evidence based practice
evidence-based medications
evidence-based practices
evidence-based therapies
evidence-based treatments
exchange malfunctioning heartmate ii lvads
excised
exercise
exercise adherence
exercise duration
exercise group
exercise modality
exercise performance
exercise programmes
exercise protocol
exercise time
exercise training
exercise training response
exercise training therapy
exercise-induced
exercise-induced pulmonary artery
exertion
exogenous variants induced
expenditure
expenditures
explant-derived progenitor cells
exposed group
externally validated
extracorporeal
extracorporeal membrane oxygenation membrane
extreme deciles
factorial trial
factors
failing fontan
failing heart
failing hearts
failure
failure of cardiovascular reserve
families
fat
fat loss
fat mass index
fat-free mass index
fat/lean body mass ratio
fatal
fatigue
fee-for-service beneficiaries
fes group
fetal gene program
few treatments
ff
fg
fiber
figure
filling formalism
filling pressure response
filling time
financial burden
financial costs
financials
first hf hospitalization
first-time diagnosis of heart failure
fish lacking
fit
fixed ring
fixed-rate atrial pacing
flow-mediated dilatation diameter
flutter
follow-up echocardiograms
follow-up exercise capacity
follow-up measurement
follow-up medication
follow-up tests
follow-up visits
force
forkhead box
fpassive-sarcomere length relations
fractional
framingham heart study criteria
free-breathing pulse sequence
full-length scn5a
function
functional abnormalities
functional class ii
functional decline
functional deficits
furosemide dose
futility
g-protein-coupled receptor kinase-2
gating movement
gdmt-treated nyha
gem
gene programs
general hospital
general linear models
general population
genes coding
genomic reprogramming events
genomic scale
gg
gh
gh-nyha-iii
ghm
ght
gln27
global longitudinal strain
global proteomics
gls outperformed left ventricular ejection fraction
glu27
glu27 haplotype
glucose transporter
gly16
grading of recommendations assessment
gross national income per capita
grounded theory
gtpase rac1
guideline
guideline-heart failure registry
guideline-recommended drugs
guideline-recommended medications
guideline-recommended treatment
guidelines-heart failure
h-dko mice
habb
habc
haemodynamic stress
hand grip strength
handling
hano donor
hapef
hawp
hawt
hdl function
hdl particles
hdl-bound malondialdehyde
hdl-induced no production
hdl-mediated protective effects
hdl-mediated vascular effects
health abc
health behaviors
health care expenditures
health care system
health initiative
health insurance
health insurance board
health interventions
health outcomes
health per capita
health service
health service planning
health status
health system
health systems
health-care budget
healthcare common procedure codes
healthcare programmes
healthy cardiomyocytes
healthy control
heart failure adherence
heart failure admission
heart failure admissions
heart failure clinic outpatients
heart failure cost-efectiveness model
heart failure discharges
heart failure disease
heart failure efficacy
heart failure home
heart failure hospitalization
heart failure mice model
heart failure mortality
heart failure nurses
heart failure patients
heart failure prone
heart failure questionnaire
heart failure rats
heart failure risk
heart failure-related hospitalization
heart failure-related mortality
heart muscle cells
heart pathology
heart rate response
heart rate variation
heart t2
heart team
heart transplant recipients
heartmate ii devices
heartmate ii exchange
heartmate ii implantation
heartmate ii insertion
heartmate ii lvad
heartware intl
heartware patients
hemodynamic disorder
hemodynamic perturbations
hemodynamic status
hemodynamically unstable
hemoglobin levels
hemolysis events
hepatic function
hf admissions
hf canine electromechanics
hf cases
hf cpgs
hf epidemiology
hf evolution
hf hospital admissions
hf hospitalisations
hf hospitalization
hf induced
hf model
hf mortality
hf mortality risk
hf pathogenesis
hf patients
hf prediction model
hf progression
hf rats
hf registry
hf remodeling
hf resources
hf risk
hf risk factors
hf risk prediction
hf tissues
hf units
hf volume management
hf-action cohort
hf-induced remodeling
hf-related cachexia
hf-related morbidity
hfe
hfef
hff
hfff
hfpsi model
hfref therapy
hfrf
hfvt
hg
hg β coefficient
hgb level
hhf
high mortality
high-cost medicare
high-dose bb
high-fat diet
high-frequency
high-risk patients
high-sensitivity assay
high-volume eds
high-volume physicians
hnorm
hnorm group
hnorm groups
home telemonitoring
hospital admission
hospital days
hospital discharge
hospital length of stay
hospital mortality
hospital quality improvement
hospital quality of care outcomes
hospital rankings
hospitalization rates
hospitalized heart failure
hospitalized hf
hospitalized older adults
hospitalized patients
hr dynamics
hr variability/turbulence
hretn
hum- retn mice
hum-retn mice
human heart failure
human hf
human myocardial tissue
human rad q66p
human resistin
human retn gene
humanized male mice
humanized mouse model
humans
humoral stimuli
hvad devices
hypertrophied heart
i-meta-iodobenzylguanidine
i-mib
i-mibg
i-mig
icd-hf
icu admission
icu mortality
if inhibitor ivabradine trial
il6)
imaging
immunoreactive nt-probnp
impact of frailty
impact of heart magnetic resonance imaging
impaired cardiac energy metabolism
impaired cardiac metabolic gene expression
impaired lv relaxation
impaired right ventricular pump
impaired systolic function
implantable cardioverter
implantable cardioverter defibrillator-crt
implantable cardioverter-defibrillator deactivation
implantable cardioverter-defibrillator deactivation preferences
implantable cardioverter-defibrillator device
implantable cardioverter-defibrillator therapy
implanted left-to-right interatrial shunt
implanted monitoring devices
in conjunction
in vivo assessment
in vivo inhibition
in-hospital adverse events
in-trial resource
inactive
inappropriate atp
inappropriate shock therapy
inappropriate therapy
incessant ventricular tachycardia storm
incident
incident cardiovascular events
incident hf
incident systolic heart failure
income
incubation
index admission
index ami
index beat method
index ed
indices
induce heart failure
induced
induced myocardial infarction
induced pluripotent stem cell-derived cardiomyocytes
inducible myocardial ischemia
inducing hyperkalemia
induction
industrial areas
infancy
infarcted hearts
infarcted left ventricle
infarcted rats
infarction-related refractory right heart failure
inflammation-stimulated resistin levels
inflammatory abdominal
inflammatory biomarkers
inflammatory markers
inflammatory stimuli
influx
inhibition of protein kinase
inhibition of vascular endothelial growth factor
inhibitor jq1
inhibitory actions
inhospital mortality
inhospital outcomes
inoperable chronic thromboembolic pulmonary hypertension
inotrope-dependent
inpatient admissions
inpatient records
insertion
insulin action
insulin receptor substrates
insulin-signaling
insulin-stimulated rates
insurance
intact hearts
interaction effect
interest
interleukin receptor family
intermediate
intermediate frail
intermediate frailty
intermediate metabolism
intermuscular fat ratio
internal consistency
internal reliability
interventions
interventricular septum biopsies
intestinal morphology
intracellular antiadrenergic
intravenous atropine
intravenous bolus of metoprolol
intravenous inotropes
intravenous iron
intravenous metoprolol
intrinsic left ventricular dysfunction
intubation rates
invasive hemodynamic
ip
irael
iron
iron deficiency
iron-deficient adult patients
irs2 double-knockout
irs2 proteins
is
ischemic etiology
ischemic hf pathogenesis
ischemic samples
isolated cardiomyocytes
isolated coronary artery bypass
isolated heart rate
isolated heart transplant
isolated heartmate ii
isolated heartmate ii lvad
isolated hr reduction
isolated lvad
isolated myoctyes
isolated pump replacement
isoprenaline infusion
iv hf
ivabradine group
ivabradine unloads
ivabradine-treated patients
japanese heart failure
jehovah
joint associations
joint effect
kaiser permanente northern california
kansas city cardiomyopathy
kaplan-meier
kccq scales
kidney index
kidney index score
kir
kv4.3 channel mrnas
kv4.3 mrna levels
l-dko mice
l-type ca2
l-type channel inhibition
l-type channel isoforms
l-type channel-dependent
label-free shotgun proteomics
laboratory
laboratory report
laboratory report model
lack of hypertension
lad models
lancet
late-activated lateral wall
late-onset
late-onset hf
lateral
lc-ms
lcx model
leaflet motion
leaflet repair
leaflet resection
lean zsf1
left
left anterior descending
left main
left ventricular assist device implantation
left ventricular biopsies
left ventricular function assessment
left ventricular longitudinal systolic strain
left ventricular mechanics
left ventricular midpapillary level
left ventricular systolic
left ventricular tissue
left-hand grip
left-to-right interatrial shunting
leg strength
legal majority
length
length-force relationship
leu3-gly4
lf/hf ratio
liberal transfusion protocols
life
life-sustaining treatment
limits of agreement
lipid-lowering therapy
literature
littermate
load-corrected chronotropic response
log2
logistic analysis
logistic regression models
lokomat® system
long-acting insulin
long-term mortality
long-term ventricular assist device
longitudinal change
longitudinal performance
longitudinal strain
low bp
low left ventricular ejection fraction
low left ventricular ejection fractions
low pasp
low testosterone status
low-dose bb
low-dose dopamine
low-dose nesiritide
low-frequency
low-sodium dash diet
low-volume ed cases
low-volume eds
low-volume physicians
lower limbs
lung weight
lv structure
lv systolic dysfunction
lv systolic indices
lvad implantation
lvad insertion
lvad surgery
lying
m7
mad-crt
madit-crt trial
magnetic
magnetically levitated centrifugal-flow chronic lvas
magnetically levitated left ventricular assist system for treating advanced hf
magnetically levitated rotor
maintenance
maladaptive cardiac remodelling
maladaptive molecular
maladaptive remodelling
male sex
malignancies
malondialdehyde bound
mammalian
management
management of heart failure
management strategies
managing
markers
markers of hemostasis
mass
mass spectrometric
matched controls
md
mean
mean ejection fraction
mean pressure gradient
mechanical
mechanical cardiac
mechanical dyssynchrony
mechanical support devices
mechanism
mechanism of action
mechanism of cardioprotection
mechanisms
mechanisms of disease
median
median age
median egf
medicaid services
medical conditions
medical hospitalization
medical management
medical outcomes
medical records
medical resource
medical staff
medical support
medical therapies
medical treatment guidelines
medicare coverage
medicare fee-for-service
medicare inpatient data
medication regimen
mediterranean
mediterranean and dietary approaches
mena levels
mesenchymal transition markers
metabolic abnormalities
metabolic enzymes
metabolic risk factors
metric
mi-induced decreases
miania
mice
midwestern state
migration
minnesota living with heart failure
mir-25 expression
mistargeting
mitochondrial complex
mitochondrial damage induced
mitochondrial dysfunction induced
mitochondrial oxidative stress induced
mitochondrial proteome changes
mitochondrial ultrastructural changes
mitochondrial-targeted antioxidant
mitochondrial-targeted peptide drugs
mitochondrial-targeted peptide ss31
mitral e/e
mitral filling flow volume
mitral stenosis reversed
mlhf
modifiable risk factors
molecular biomarkers
molecular mechanism
monitoring board
morpholino-based knockdown
morphological
mortality outcomes
mortality predictors
mortality rate
mortality rates
mortality risk
mouse
mouse heart
mouse heart failure
mouse hearts
mouse hf model
mouse myocardium
mouse rad q65p
mouse tac model
mri-based models
mrna level
mrna levels
mt
mt group
multicenter automatic defibrillator implantation
multihospital
multimarker-based strategy
multiparametric echocardiographic score
multivariate cox regression
murine equivalent
murine myocardium
murine resistin
muscle function
muscle strength
muscle strip stiffness
muscle strips
muscle wasting
muscle-wasting syndrome
muscular strength
mutant
mutant mice
mv
mwt
myocardial delayed enhancement imaging
myocardial extracellular matrix accumulation
myocardial glycolysis
myocardial infarction-both
myocardial loss
myocardial pde2
myocardial pde2 expression
myocardial phosphodiesterase-2
myocardial titin hypophosphorylation
myocyte diameter
myofiber shortening onset
myofiber shortening velocity
myofibrillar ca(2+)-stimulated atpase activity
myofilament ca(2+) sensitivity
myosin binding protein-c phosphorylation
n
n-
n-terminal fragment
na+ channel mrna splice
na+ current
na-terminal probnp
nad(ph-oxidase
nafat
nafat signalling
nanomolar doses
national cardiovascular disease registry
natriuretic peptide levels
natriuretic peptide system
natural vasodilatory
ncd pinnacle
nct00180271)
negative coronary angiography
negative cross talk
negative likelihood ratio
neonatal rat
neprilysin blocks
neprilysin inhibitor prodrug
nesiritide strategy
net reclassification
neurohormonal abnormalities
neurohormonal activation
neurohormonally induced heart disease
neutral endopeptidase inhibitors
new-onset esrd
new-onset post-lvad ai
nicorandil ameliorates mitochondrial dysfunction
nights
ninth revision
nitric oxide donors
no production
non-aas
non-biological disease
non-diabetic patients
non-diastolic abnormalities
non-dnx
non-fatal stroke
non-frail
non-hf
non-ischemic
non-lbbb
non-linear hr variability
non-sudden cardiac death
nonadherence
noncardiac
noncardiologist
noncardiovascular diagnoses
noncardiovascular drugs
noncoding rnas
nondiabetes risk factors
nondiabetic patients
nonfatal outcomes
nonfunctional channels
nonglycosylated
nonmitochondrial protein changes
nonpace
nonpace dnx
nonselective
nonsurvivors
nontrastuzumab
nontraumatic death
nontreatment
nordic walking
nordic walking led
norepinephrine-induced hypertrophic responses
normal albumin
normal geometry
northwest united states
np assessment
np levels
np measurement
nt-probnp assay
nt-probnp cutoff point
nt-probnp levels
nt-probnp testing
nuclear factor
nurse assessment
nurse leaders
nursing care
nursing management
nursing terminologies
nursing-sensitive outcome change scores
nursing-sensitive outcome measures
nutrition
nutritional abnormalities
nuts
nyha ii-iii
o-1 signaling
o2 consumption rate
obese body mass index
obese participants
obese zsf1
off-pump
office hours
oht bridged
onset of heart failure
open chest model
open stent
open surgery
opening
operating characteristic curve
oral glucocorticoid
oral glucocorticoids
organic lesion
organisation of care taxonomy
oscillatory ventilation
out-patient follow-up
outcome performance
outcome-monitoring phase
outline
outpatient assessments
outpatient models
outpatient settings
overweight
oxidative stress markers
oxygen
oxygen consumption
oxygen flow
p38alpha mapk
p38α mitogen-activated protein kinase
p70s6k-ser
pace
pace non-dx
paced groups
paced myocardium
paediatric cardiac transplants
paediatric heart failure
paf biosynthetic enzymes
paf levels
parasympathetic function
parasympatic activity
partial pressure
pasp relationship
passive/stiffness
pathological cardiac gene expression programme
pathological changes
pathological gene expression
pathological gene induction
pathological heart disease
pathological hypertrophy
pathological remodelling
pathological stress
pathophysiologic mechanism
pathophysiologic mechanisms
pathophysiologic state
pathway alterations
pathway analysis
patient consultation
patient management interventions
patient outcomes
patient preferences
patient safety
patient-level regression
pay-for-performance
pb cycle
pde superfamily
pde2 activity
pde2 expression
pde2 overexpression
pde2-overexpressing cardiomyocytes
peak
peak aerobic capacity
peak ca(2+) transient
peak o2 per kilogram
peak respiratory
pediatric heart failure
pediatric mechanical cardiac
pediatrics
penalties
percutaneous coronary revascularization
performance
peripheral abnormalities
periprocedural
perk activation
perk inhibition
permanent periodic breathing
permeability
perturbed mitochondrial function
pevk segment
pf cohort
pf-acetylhydrolase
pf-ah
pf-cpt
pg/ml
pharmacologic studies
pharmacologic therapies
pharmacological armamentarium
phenylephrine-induced genes
phosphomimic ser77
physical activity
physical exertion
physical exhaustion
physical volume
physician adherence
physician continuity
physician follow-up
physician volume
physio ring
physiologic processes
physiological proteolysis
pigs
pilot trial
pkc-βii-ser
placebo group
placebo-controlled clinical trial
placebo-treated patients
plasma collected
plasma samples
plasticity
plateau phase
pluripotency marker nanog
poc measurement
point-of-care systems
policy recommendations
polytetrafluoroethylene tube
poorer vo2
porcine model
positron emission tomography imaging
post myocardial infarction
post-aac
post-acute care transfer policy
post-dash
post-hct chf
post-myocardial infarction heart
post-pd initiation
post-tac cardiac
post-translational
post-translational state
post-translational states
post-transplant
post-transplant morbidity
posterior wall thickness
posteriorly displaced papillary muscles
postmarketing trials
postmenopausal women
postnatal mammalian myocardium
postoperative echocardiography
postoperative months
postoperative mortality
postoperative normalization
postoperative survival
postystolic function
power spectral
pp
practice
practice innovation
practice-level variation
practices
pre-crt lv
pre-hct
pre-hct germline dna
pre-pd
precipitating factor
prediction rule
predictor
predictors
predictors of mortality
preferences
preoperative albumin
preoperative demographics
preoperative hypoalbuminemia
preoperative renal dysfunction
preoperative serum albumin levels
prescribing guideline-recommended medications
preserved
preserved cardiac index
preserved systolic function
pressure
pressure gradient
pressure-overload-induced hypertrophy
pressure-volume conductance
primary care clinicians
primary diagnosis
primary isolated cabg
principal discharge diagnosis
prior stroke score
pro2- leu3
pro6-gly7
pro75-arg76
proangiogenic effects
procedures
process redesign
processes of care delivery
prognostic benefit
prognostic factors
prognostic power
prognostic resolution
progression
progressive disease
propensity
propensity score decile
prostate
protective mechanisms
protective peptides
protein levels
protocol-driven poc testing
province of alberta
province of québec
proximal circumflex artery
proximal lad
proximal lad model
proximal left anterior descending artery
pss
psychometric profile
psychometric testing
psychosocial factors
public health
public reporting
publicly
pulmonary arterial hypertension medication
pulmonary arterial systolic pressure relationship
pulmonary artery snared
pulse-wave velocity
pump exchanges
pump failure
pump malfunctions
pump replacement
pump-exchange technique
pure epicatechin
pyridostigmine administration
quality
quality of life score
quality-of-life score
quartile of e/e
r-r interval oscillations
r. cluster
rabbits
race
race/ethnicity
rad on cav1.2
rad q66p
rad q66p limits
radial artery tonometry
radioenzymatic- and fluorescence resonance energy transfer-based assays
raised blood glucose levels
randomized trials
ras-
ras-blocker uptitration
rat
rat metabolic risk model
rat model
rate
rate of death
rate-control patients
rate-control strategies
ratio
ratio ees
ratio of phosphocreatine
ratio of systolic blood pressure
ratios
rats
readmission metrics
readmission quality
readmission rate
readmission rates
readmission reduction program
receiver
receiver operating characteristic curve
receptor antagonist
recipients
reciprocal downregulation
reciprocal regulation
reclassification
recommended therapies registry
recovery
recovery period
recreational athletes
reduced ejection
reduction
refill compliance
refractory
regression
regulate expression
regulates ventricular action potential duration
regulation
regulation of feeding
regulation of programmed cell death
regulator of growth
regulatory
relative appendicular lean mass index
relative value
relaxation
religious beliefs
renal atherosclerotic lesions
renal function end point
repeat ed visits
reperfusion therapy
repolarization instability
repolarization lability
report
reporting
research
residual confounding
resistance training
resistin correlated
resistin levels
respiratory gas
response
restrictive red blood cell transfusion strategy
resynchronization reverses remodeling
resynchronization-defibrillation
retention trial
retrospective co
reversal of changes
reverse cardiac remodeling
reverse remodeling parameters
reversibility
reversible myocardial ischemia
reviews and dissemination
rhythm
rhythm- and rate-control strategies
right atrial area
right atrial mass removal
right atrium mass
right grip strength
right heart foundation
right ventricle overload leads
right ventricular contractile
right ventricular fractional area change
risk
risk model
risk of death
risk of event
risk of hospitalization
risk predictor
risk reduction
risk-adjusted all-cause mortality
risk-adjusted mortality
riα proteins
rna polymerase ii
robot-assisted gait therapy
robot-assisted training
rose acute heart failure
rotterdam
routine measurement
rr intervals
rule
rv failure management
s'lateral
s'septal
s1pr
s1pr1 cardiac gene therapy
s2
saf cohort
safety
salt
salt intake
sarcomeric
sarcopenic range
scaffold protein drives
schfi
sci
science
scientific literature
scn5a transcript
sd testosterone levels
sdqt-to-sdr ratio
sdr
seattle heart failure model-predicted survival
self-care
self-care confidence scale
self-care management scale
self-care of heart failure index
self-management counseling
self-management training
self-reported physical activity
septal correlated
septal defects
septal wall cs
sequential phosphorylation
ser23/24 troponin i phosphorylation
ser83 phosphorylation
serial evaluation
serum
serum factors
serum levels
serum potassium level
serum resistin levels
serum sodium levels
severe anemia
severe cad
severe end-stage hf
severe hyperkalemia
severe hypertension
sex
sex-adjusted risk
sham
sham explants
sham group
sham levels
sham-innervated
sham-inv
sham-nx
sham-operated
sham-operated animals
shams
sheet orientation
short physical performance battery
short-form quality of life
short-term mortality rates
shortened lvet
shortness of breath due to lung congestion
shotgun
shunt implantation
shunt implants
signal
signal transduction cascade
signaling
signaling paradigms
signalling cascades
signed-rank tests
skeletal muscle abnormalities
skeletal muscle mass
skeletal muscle mass correlated
skeletal muscle sarcomere structure
skilled nursing facilities
skinfold thickness
skm biopsies
skm growth
slowed conduction
slowness
smad
small-molecule inhibitors
smoked
smoking
smoking cessation
sn5a
snared
snp rs10927887
social mandate
social support
socioeconomic status
sodium-restricted dash diet
sodium-restricted dietary
solid ehrlich carcinoma
soluble guanylate cyclase
soluble st2
southeastern minnesota
sphingosine-1-phosphate receptor
spironolactone dose
spontaneous cardiac dysfunction
sport
sprague-dawley rats
sr ca(2+)-pump function
srd
sst2 measurement
sst2 titrated
sst2/high-dose bb
sst2/low-dose bb
st2 levels
stable coronary artery disease
stable hfpef
stage i-iii breast cancer
standard cardiac rehabilitation
standard care
standard heart failure medicines
standard practice
standing blood pressure
statistical standards
statitistical
stem cell source
stent coated
sternal sparing
stockholm national inpatient registry
stop hypertension
strain rate
strategy
stress
stretch rate
stroke prevention trial
strong acid
structural heart disease
structurally normal hearts
sts hh
sts hm
study closure
subcellular alterations
subclinical atherosclerosis
subunit expression
sudden
sudden cardiac death
sudden cardiac deaths
sudden death
surface ecgs
surgical conditions
surgical indication
surgical method
surgical patients
surgical ring implantation
surgical tactics
survival
survival projections
survival study
svr index
swedish web-system for enhancement and development of evidence-based care
swine
swine model
sympathetic control
synchrony
systolic heart failure treatment
systolic human heart failure
t test
t1 changes
t1-mapping mri
t1-mapping sequence
t1-mapping technique
t24/7
tac surgery
tac-
tac-induced proteomic
tachy-
tachycardia-induced heart failure
tachycardic response
tapse-to-pasp ratio
target sodium
taxonomy
technical advisors
telehealth system
temporary centrimag rvad
tension
tertiary referral centre
test-retest reliability
testosterone group
tests
tests-retest reliability
texas cancer registry-medicare databases
tg
tg-β
tg-β inhibition
tg-β receptor
tg-β signaling
tgtttmena
tgtttmena mice
tgttttmena
thalassaemia
therapeutic interruption
therapy refractory cardiogenic shock
thickness
thigh muscle
time domain
time to death
tissue
tissue doppler imaging
tissuefaxs technology
titin isoforms
titin modification
tm interventions
to death
tobacco
tonometric indices
total adiponectin
total cholesterol
toxicity
tpse
training-induced changes
trans
transcription
transcription factor dhand
transcription factor gata4
transforming growth factor
transgenic mice
transient receptor potential cation channel
transition
transitions of care
translational repression
transmitral e-wave
transmitral flow velocities
transplant ineligible patients
transplant pool
transplant-ineligible patients
transplantation eligibility status
trastuzumab-related cardiotoxicity
trastuzumab-related chf
trastuzumab-treated patients
trastuzumb-related chf
treadmill exercise testing
treadmill testing
treatment
treatment algorithms
treatment for heart failure
treatment group effects
treatment strategies
treatments
trial
trial-cardiac resynchronization therapy
trials
trichrome blue histologic
trigger hemoglobin threshold
trp7) channel mrna
truncated
truncated na+ channels
tta
tuel assay
turbulence
twist
two-vessel disease model
two-vessel model
u.s. food and drug administration
ultrastructural
um
um/va
unanchors titin
unclear etiology
uncontrolled hypertension
underlying heart disease
undiagnosed heart disease
unfamiliar physician
unfavorable outcome
unfit
unfit men
unilateral
unintentional weight loss
unit costs
university hospital
unloading of the heart
unplanned admission
unplanned readmission
untranslated region
untreated acf groups
upr effectors
upstream signal
urgent all-cause readmission
urgent cardiac transplant
urgent readmission
usual care
uv
v
va
va health care systems
va-rt
va-rt cohort
va-rt cohorts
vad group
vad groups
vagal
vascular effects
vasodilator effects
vasopressin receptor antagonist therapy
vco2 slope
vegetables
vegf2
vegfr2
vehicle
vehicle-treated rats
velocity
velocity time
ven
venous thrombolic events
ventricular ejection fraction
ventricular power index
ventricular systolic hf tissue samples
ventricular wall stress
ventricularly paced
vet
veterans
via echocardiography
viscoelastic
vitro
vivo phosphorylation sites
voltage-gated cardiac na+ channel α-subunit
volume
waist circumference
walk distance
walk test
walk test distance
walking
wasting
water
wave doppler echocardiography
wave ratio
waves
weak grip
weight
weight loss
well-being
western australian
western society
wha
white
white rabbits
whole grain intake
wilcoxon
wild type
wild-type littermates
wistar rats
withdrawal of sympathetic tone
witness
women
working hearts
workload
wrf
writer
wstar-kyoto
wt riα
yielded hazard ratios
yorkshire swine
young
zebrafish
zf1 groups
zf1 rats
zsf1 group
zsf1 groups
zung
β-adrenergic receptor activation
β-ar drive
β-blocker uptitration
β-blocker uptitrations
β-blocker-induced enhancement
β-blockers therapy
β1ar overstimulation
β2-receptor haplotype status
